Oncodesign Precision Medicine SA (ALOPM)

Paris
Currency in EUR
0.41
+0.03(+8.47%)
Real-time Data·
ALOPM Scorecard
Full Analysis
High shareholder yield
ALOPM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.400.41
52 wk Range
0.281.38
Key Statistics
Edit
Prev. Close
0.38
Open
0.4
Day's Range
0.4-0.41
52 wk Range
0.28-1.38
Volume
3.47K
Average Volume (3m)
12.18K
1-Year Change
-62.93%
Book Value / Share
-0.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALOPM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.00
Upside
+387.80%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Oncodesign Precision Medicine SA Company Profile

Oncodesign Precision Medicine Société anonyme, a biopharmaceutical company, engages in the precision medicine business. The company’s product pipeline consist of OPM-101, a potentially inhibitor of the RIPK2 target, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; OPM-102, a novel inhibitor that is in preclinical studies for the treatment of cancer; and OPM-201, a potential LRRK2 inhibitor, which is in Phase 1 clinical trial for the treatment of Parkinson’s disease. It is also developing drugs for the treatment of pancreatic and other cancers. The company has a strategic collaboration agreement with Navigo Proteins GmbH for the discovery and development of new systemic radiotheranostic agents. Oncodesign Precision Medicine Société anonyme was founded in 1995 and is based in Dijon, France.

Compare ALOPM to Peers and Sector

Metrics to compare
ALOPM
Peers
Sector
Relationship
P/E Ratio
−1.0x−2.1x−0.5x
PEG Ratio
−0.050.030.00
Price/Book
−16.1x1.3x2.6x
Price / LTM Sales
4.2x5.9x3.1x
Upside (Analyst Target)
-187.2%45.7%
Fair Value Upside
Unlock9.6%5.7%Unlock

Analyst Ratings

0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Strong Sell

Analysts 12-Month Price Target:

Average 2.00
(+387.80% Upside)

Earnings

Latest Release
Apr 23, 2025
EPS / Forecast
-- / --
Revenue / Forecast
1.04M / --
EPS Revisions
Last 90 days

ALOPM Income Statement

People Also Watch

0.2610
ALJXR
-0.19%
21.95
MANP
+2.09%
0.1044
ALTME
+0.97%
0.842
ALVAL
+1.45%
16.780
VLLP
-0.59%

FAQ

What Is the Oncodesign Precision Medicine (ALOPM) Stock Price Today?

The Oncodesign Precision Medicine stock price today is 0.41

What Stock Exchange Does Oncodesign Precision Medicine Trade On?

Oncodesign Precision Medicine is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Oncodesign Precision Medicine?

The stock symbol for Oncodesign Precision Medicine is "ALOPM."

What Is the Oncodesign Precision Medicine Market Cap?

As of today, Oncodesign Precision Medicine market cap is 6.87M.

What Is Oncodesign Precision Medicine's Earnings Per Share (TTM)?

The Oncodesign Precision Medicine EPS (TTM) is -0.40.

From a Technical Analysis Perspective, Is ALOPM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Oncodesign Precision Medicine Stock Split?

Oncodesign Precision Medicine has split 0 times.

How Many Employees Does Oncodesign Precision Medicine Have?

Oncodesign Precision Medicine has 18 employees.

What is the current trading status of Oncodesign Precision Medicine (ALOPM)?

As of 10 July 2025, Oncodesign Precision Medicine (ALOPM) is trading at a price of 0.41, with a previous close of 0.38. The stock has fluctuated within a day range of 0.40 to 0.41, while its 52-week range spans from 0.28 to 1.38.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.